📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Egen

1.1 - Company Overview

Egen Logo

Egen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of safe, efficient delivery systems for the manufacture of nucleic acid and anti-cancer drugs and for creating products to treat human diseases, offering synthetic biocompatible delivery vehicles to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA), and small molecules.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Egen

Santaris Pharma Logo

Santaris Pharma

HQ: Denmark Website
  • Description: Provider of RNA-targeted therapy discovery and development using proprietary LNA chemistry through its LNA Drug Platform and Drug Discovery Engine; a privately held, clinical-stage biopharmaceutical company focused on highly specialized, targeted drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Santaris Pharma company profile →
Akouos Logo

Akouos

HQ: United States Website
  • Description: Provider of AAV vector-based gene therapies to restore and preserve hearing in genetically defined patient populations, addressing causes from single gene mutations to ototoxic drug exposure and aging. Offers AK-OTOF, a gene therapy targeting sensorineural hearing loss due to otoferlin mutations, and the Resonate Program, no-cost genetic testing with optional counseling for auditory neuropathy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Akouos company profile →
Biogazelle Logo

Biogazelle

HQ: Belgium Website
  • Description: Provider of genomic testing solutions and expert laboratory services in nucleic acid quantification—including gene expression, mutation, and copy number analysis—and antisense oligonucleotide screening to support development of diagnostics and therapeutics. Offers customized workflows for clinically relevant samples, from liquid biopsies to fixed tissues.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biogazelle company profile →
Kate Therapeutics Logo

Kate Therapeutics

HQ: United States Website
  • Description: Provider of AAV-based gene therapies targeting genetically defined muscle and heart diseases, supported by the DELIVER capsid engineering platform for evolving tissue-targeted AAV variants, MyoAAV muscle-tropic capsids for skeletal and cardiac delivery, and cargo technologies to enhance regulation, targeting, and safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kate Therapeutics company profile →
Spark Therapeutics Logo

Spark Therapeutics

HQ: United States Website
  • Description: Provider of potentially curative, one-time gene therapy treatments for genetic diseases, including investigational programs such as SPK-8011 for hemophilia A, fidanacogene elaparvovec (SPK-9001) for hemophilia B, SPK-3006 for Pompe disease, and gene therapies targeting Stargardt and Huntington’s diseases, plus AAV-based research programs for the retina, liver, and central nervous system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spark Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Egen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Egen

2.2 - Growth funds investing in similar companies to Egen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Egen

4.2 - Public trading comparable groups for Egen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Egen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Egen

What does Egen do?

Egen is a provider of safe, efficient delivery systems for the manufacture of nucleic acid and anti-cancer drugs and for creating products to treat human diseases, offering synthetic biocompatible delivery vehicles to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA), and small molecules.

Who are Egen's competitors?

Egen's competitors and similar companies include Santaris Pharma, Akouos, Biogazelle, Kate Therapeutics, and Spark Therapeutics.

Where is Egen headquartered?

Egen is headquartered in United States.

How many employees does Egen have?

Egen has 1,000 employees 🔒.

When was Egen founded?

Egen was founded in 2010 🔒.

What sector and industry vertical is Egen in?

Egen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Egen

Who are the top strategic acquirers in Egen's sector and industry

Top strategic M&A buyers and acquirers in Egen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Egen?

Top strategic M&A buyers groups and sectors for Egen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Egen's sector and industry vertical

Which are the top PE firms investing in Egen's sector and industry vertical?

Top PE firms investing in Egen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Egen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Egen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Egen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Egen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Egen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Egen?

The key public trading comparables and valuation benchmarks for Egen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Egen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Egen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Egen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Egen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Egen's' sector and industry vertical?

Access recent funding rounds and capital raises in Egen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Egen

Launch login modal Launch register modal